FDA Issues New Draft Guidance for PET Drugs
The US Food and Drug Administration has released a new draft guidance clarifying IND requirements for radioactive drugs used in positron emission tomography scanning. Clinical use after June 12, 2012, will require an approved marketing application or an expanded access…